Capital Ideas Media publisher Mark Bunting sits down with George Robinson, CEO of RavenQuest BioMed (CSE:RQB), and a thought leader in the sector. Robinson pulls the curtain back on the company’s unique technology, production growth, revenue and profitability projections, EU play, and First Nations and McGill University partnerships. RavenQuest BioMed has been building out and proving out for the last year, is now ready for prime time, and investors are waking up to the story.
PLEASE SIGN UP FOR OUR FREE DAILY EMAIL, “THE MORNING NEED TO KNOW” TO HELP GET YOU READY FOR YOUR INVESTMENT DAY CAPITALIDEASMEDIA.COM
FULL DISCLOSURE: NOTHING ON THIS SITE SHOULD EVER BE CONSIDERED TO BE ADVICE, RESEARCH OR AN INVITATION TO BUY OR SELL ANY SECURITIES, PLEASE SEE MY TERMS & CONDITIONS PAGE FOR A FULL DISCLAIMER.